Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 203, Issue 7, Pages 1637-1642Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20052203
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01RR018535, M01 RR018535] Funding Source: Medline
- NIGMS NIH HHS [R01 GM062508] Funding Source: Medline
Ask authors/readers for more resources
Severe sepsis, a lethal syndrome after infection or injury, is the third leading cause of mortality in the United States. The pathogenesis of severe sepsis is characterized by organ damage and accumulation of apoptotic lymphocytes in the spleen, thymus, and other organs. To examine the potential causal relationships of apoptosis to organ damage, we administered Z-VAD-FMK, a broad-spectrum caspase inhibitor, to mice with sepsis. We found that Z-VAD-FMK-treated septic mice had decreased levels of high mobility group box 1 (HMGB1), a critical cytokine mediator of organ damage in severe sepsis, and suppressed apoptosis in the spleen and thymus. In vitro, apoptotic cells activate macrophages to release HMGB1. Monoclonal antibodies against HMGB1 conferred protection against organ damage but did not prevent the accumulation of apoptotic cells in the spleen. Thus, our data indicate that HMGB1 production is downstream of apoptosis on the final common pathway to organ damage in severe sepsis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available